Hubei Gedian Humanwell Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Hubei Gedian Humanwell focuses on R&D, production, & sales of fertility regulation drugs & steroidal APIs.
One of their notable products is OXCARBAZEPINE, with a corresponding US DMF Number 32999.
Remarkably, this DMF maintains an Active status since its submission on July 22, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 12, 2019, and payment made on February 12, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II